发明授权
US08513213B2 SDF-1 delivery for treating ischemic tissue 有权
用于治疗缺血组织的SDF-1递送

SDF-1 delivery for treating ischemic tissue
摘要:
A method of treating a cardiomyopathy in a subject includes administering directly to or expressing locally in a weakened, ischemic, and/or peri-infarct region of myocardial tissue of the subject an amount of SDF-1 effective to cause functional improvement in at least one of the following parameters: left ventricular volume, left ventricular area, left ventricular dimension, cardiac function, 6-minute walk test, or New York Heart Association (NYHA) functional classification.
公开/授权文献
信息查询
0/0